Beta Bionics
BBNX
116 hedge funds and large institutions have $659M invested in Beta Bionics in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 37 increasing their positions, 28 reducing their positions, and 13 closing their positions.
115% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 13
32% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 28
30% more capital invested
Capital invested by funds: $508M → $659M (+$151M)
14% more funds holding
Funds holding: 102 → 116 (+14)
7.25% more ownership
Funds ownership: 96.2% → 103.45% (+7.2%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$21.9M |
| 2 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$13.4M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$12.3M |
| 4 |
VPC
Vestal Point Capital
New York
|
+$7.79M |
| 5 |
Millennium Management
New York
|
+$7.68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$12.8M |
| 2 |
BlackRock
New York
|
-$8.05M |
| 3 |
PVI
Pura Vida Investments
New York
|
-$6.04M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$5.75M |
| 5 |
Holocene Advisors
New York
|
-$4.77M |
BBNX Hedge Fund Activity: Q2 2025 in Review
116 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Beta Bionics (BBNX) for Q2 2025, worth a combined $659M — up 30% from $508M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new BBNX positions and 13 closed out — a net gain of 15 holders — while 37 added to existing stakes and 28 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $21.9M. The largest seller was AllianceBernstein, cutting an estimated $12.8M.
- 116 institutional investors held Beta Bionics (BBNX) as of Q2 2025, up from 102 in Q1 2025.
- Funds reported $659M of Beta Bionics stock for Q2 2025, up 30% quarter-over-quarter.
- 28 funds opened new Beta Bionics positions in Q2 2025 and 13 closed out, a net change of +15 holders.
- The largest Beta Bionics buyer in Q2 2025 was Morgan Stanley, an estimated $21.9M added.
- The largest Beta Bionics seller in Q2 2025 was AllianceBernstein, an estimated $12.8M sold.
Based on aggregated 13F filings for Q2 2025.